Home Diagnostics, Inc. announced unaudited consolidated financial results for the third quarter and nine months ended September 30, 2009. Total revenue for the third quarter was $34.5 million, a decrease of 3.0% from $35.6 million in the third quarter of 2008. Operating income for the third quarter of 2009 was $4.2 million, compared to operating income of $6.2 million for the third quarter of 2008. For the three-month period ended September 30, 2009, the Company reported net income of $2.9 million, or $0.17 per diluted share, based on weighted average shares outstanding of 17.6 million. Net income for the three-month period ended September 30, 2008 was $4.5 million, or $0.24 per diluted share, based on 18.8 million weighted average shares outstanding. Income before provision for income taxes was $4.2 million against $6.3 million a year ago. Cash provided by operating activities was $4.2 million against $3.1 million a year ago. For the nine months, the company reported net sales of $91.7 million, income from operations of $4.6 million, income before provision for income taxes of $4.7 million and net income of $3.1 million or $0.18 per diluted share against net sales of $94.0 million, income from operations of $10.3 million, income before provision for income taxes of $10.5 million and net income of $7.9 million or $0.42 per diluted share for the same period a year ago. Cash provided by operating activities was $5.6 million against $9.3 million a year ago. The company is adjusting its full year 2009 guidance. It now expects total revenue to be in the range of $126 million to $127 million and diluted earnings per share to be in the range of $0.30 to $0.32 from the previous estimate of $129 million to $131 million and diluted earnings per share in the range of $0.36 to $0.38.

Home Diagnostics, Inc. expected to Report Fiscal Year 2009 Results on March 1, 2010. This event was calculated by Capital IQ (Created on November 5, 2009).

Home Diagnostics, Inc. provides capital expenditure guidance for the year 2009. For the full year 2009, the company now expects total capital expenditure to be $15 million to $16 million, including approximately $9 million related to the expansion. This is down slightly from its previous expectation for total capital expenditure in 2009 of $17 million to $19 million, as a result in the shift and the expected timing and delivery of the equipment related expansion and the final payment terms.